
Trent R. Clarke
Examiner (ID: 2308, Phone: (571)272-2904 , Office: P/1651 )
| Most Active Art Unit | 1651 |
| Art Unit(s) | 1651 |
| Total Applications | 495 |
| Issued Applications | 169 |
| Pending Applications | 82 |
| Abandoned Applications | 267 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 13987285
[patent_doc_number] => 20190062800
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-28
[patent_title] => METHODS OF ATTACHING PROBES TO MICROORGANISMS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/073092
[patent_app_country] => US
[patent_app_date] => 2017-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10773
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16073092
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/073092 | METHODS OF ATTACHING PROBES TO MICROORGANISMS AND METHODS OF USE THEREOF | Jan 25, 2017 | Abandoned |
Array
(
[id] => 16220511
[patent_doc_number] => 20200245627
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-06
[patent_title] => AGRICULTURALLY BENEFICIAL MICROBES, MICROBIAL COMPOSITIONS, AND CONSORTIA
[patent_app_type] => utility
[patent_app_number] => 16/071291
[patent_app_country] => US
[patent_app_date] => 2017-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 56079
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16071291
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/071291 | AGRICULTURALLY BENEFICIAL MICROBES, MICROBIAL COMPOSITIONS, AND CONSORTIA | Jan 18, 2017 | Abandoned |
Array
(
[id] => 14372413
[patent_doc_number] => 20190160119
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2019-05-30
[patent_title] => CRYOPROTECTANTS FOR FREEZE DRYING OF LACTIC ACID BACTERIA
[patent_app_type] => utility
[patent_app_number] => 15/398945
[patent_app_country] => US
[patent_app_date] => 2017-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9984
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15398945
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/398945 | Cryoprotectants for freeze drying of lactic acid bacteria | Jan 4, 2017 | Issued |
Array
(
[id] => 14372413
[patent_doc_number] => 20190160119
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2019-05-30
[patent_title] => CRYOPROTECTANTS FOR FREEZE DRYING OF LACTIC ACID BACTERIA
[patent_app_type] => utility
[patent_app_number] => 15/398945
[patent_app_country] => US
[patent_app_date] => 2017-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9984
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15398945
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/398945 | Cryoprotectants for freeze drying of lactic acid bacteria | Jan 4, 2017 | Issued |
Array
(
[id] => 11567029
[patent_doc_number] => 20170105673
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-20
[patent_title] => 'Methods for Solubilizing Cells and/or Tissue'
[patent_app_type] => utility
[patent_app_number] => 15/396356
[patent_app_country] => US
[patent_app_date] => 2016-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 7380
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15396356
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/396356 | Methods for Solubilizing Cells and/or Tissue | Dec 29, 2016 | Abandoned |
Array
(
[id] => 11706601
[patent_doc_number] => 20170175100
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-22
[patent_title] => 'Composite of Paracoccus denitrificans immobilized on modified graphene oxide and its preparation method and application'
[patent_app_type] => utility
[patent_app_number] => 15/382625
[patent_app_country] => US
[patent_app_date] => 2016-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2699
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15382625
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/382625 | Composite of | Dec 16, 2016 | Issued |
Array
(
[id] => 11647061
[patent_doc_number] => 20170142962
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-25
[patent_title] => 'METHODS AND SOLUTIONS INCLUDING ADDITIVES AND STABILIZERS FOR KILLING OR DEACTIVATING SPORES'
[patent_app_type] => utility
[patent_app_number] => 15/358220
[patent_app_country] => US
[patent_app_date] => 2016-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 10752
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15358220
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/358220 | METHODS AND SOLUTIONS INCLUDING ADDITIVES AND STABILIZERS FOR KILLING OR DEACTIVATING SPORES | Nov 21, 2016 | Abandoned |
Array
(
[id] => 11492831
[patent_doc_number] => 20170067016
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-09
[patent_title] => 'MAINTENANCE OF DIFFERENTIATED CELLS WITH LAMININS'
[patent_app_type] => utility
[patent_app_number] => 15/351124
[patent_app_country] => US
[patent_app_date] => 2016-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 10343
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15351124
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/351124 | Maintenance of differentiated cells with laminins | Nov 13, 2016 | Issued |
Array
(
[id] => 11977620
[patent_doc_number] => 20170281775
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-05
[patent_title] => 'MODIFICATIONS OF SOLID 3-SN-PHOSPHOGLYCERIDES'
[patent_app_type] => utility
[patent_app_number] => 15/349527
[patent_app_country] => US
[patent_app_date] => 2016-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 11942
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15349527
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/349527 | MODIFICATIONS OF SOLID 3-SN-PHOSPHOGLYCERIDES | Nov 10, 2016 | Abandoned |
Array
(
[id] => 11436355
[patent_doc_number] => 20170037377
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-09
[patent_title] => 'PRODUCTION OF REPROGRAMMED PLURIPOTENT CELLS'
[patent_app_type] => utility
[patent_app_number] => 15/299088
[patent_app_country] => US
[patent_app_date] => 2016-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20878
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15299088
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/299088 | PRODUCTION OF REPROGRAMMED PLURIPOTENT CELLS | Oct 19, 2016 | Pending |
Array
(
[id] => 11401991
[patent_doc_number] => 20170022530
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-26
[patent_title] => 'PROCESSING BIOMASS'
[patent_app_type] => utility
[patent_app_number] => 15/287461
[patent_app_country] => US
[patent_app_date] => 2016-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 12669
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15287461
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/287461 | PROCESSING BIOMASS | Oct 5, 2016 | Abandoned |
Array
(
[id] => 11567415
[patent_doc_number] => 20170106059
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-20
[patent_title] => 'REDUCTION OF EGFR THERAPEUTIC TOXICITY'
[patent_app_type] => utility
[patent_app_number] => 15/280673
[patent_app_country] => US
[patent_app_date] => 2016-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 17805
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15280673
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/280673 | REDUCTION OF EGFR THERAPEUTIC TOXICITY | Sep 28, 2016 | Abandoned |
Array
(
[id] => 13481707
[patent_doc_number] => 20180292396
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-11
[patent_title] => METHOD FOR MEASURING TYROSINE PHOSPHATASE AND TYROSINE KINASE ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 15/766333
[patent_app_country] => US
[patent_app_date] => 2016-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13045
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 148
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15766333
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/766333 | Method for measuring tyrosine phosphatase and tyrosine kinase activity | Sep 25, 2016 | Issued |
Array
(
[id] => 11362844
[patent_doc_number] => 20170000825
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-05
[patent_title] => 'HUMAN FACILITATING CELLS'
[patent_app_type] => utility
[patent_app_number] => 15/267417
[patent_app_country] => US
[patent_app_date] => 2016-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 16001
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15267417
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/267417 | HUMAN FACILITATING CELLS | Sep 15, 2016 | Abandoned |
Array
(
[id] => 12240081
[patent_doc_number] => 20180072944
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-15
[patent_title] => 'Stannous Fluorescent Probe'
[patent_app_type] => utility
[patent_app_number] => 15/265899
[patent_app_country] => US
[patent_app_date] => 2016-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 6372
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15265899
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/265899 | Stannous Fluorescent Probe | Sep 14, 2016 | Abandoned |
Array
(
[id] => 11757498
[patent_doc_number] => 20170204366
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-20
[patent_title] => 'CULTURE SUBSTRATE'
[patent_app_type] => utility
[patent_app_number] => 15/265070
[patent_app_country] => US
[patent_app_date] => 2016-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 22490
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15265070
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/265070 | CULTURE SUBSTRATE | Sep 13, 2016 | Abandoned |
Array
(
[id] => 13413691
[patent_doc_number] => 20180258388
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-13
[patent_title] => METHOD FOR PRODUCING RETINAL PIGMENT EPITHELIAL CELLS
[patent_app_type] => utility
[patent_app_number] => 15/757202
[patent_app_country] => US
[patent_app_date] => 2016-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24847
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15757202
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/757202 | Method for producing retinal pigment epithelial cells | Sep 7, 2016 | Issued |
Array
(
[id] => 11348860
[patent_doc_number] => 20160367600
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-22
[patent_title] => 'Administration of Intact Mammalian Cells to the Brain by the Intranasal Route'
[patent_app_type] => utility
[patent_app_number] => 15/257821
[patent_app_country] => US
[patent_app_date] => 2016-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2514
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15257821
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/257821 | Administration of Intact Mammalian Cells to the Brain by the Intranasal Route | Sep 5, 2016 | Abandoned |
Array
(
[id] => 11712940
[patent_doc_number] => 20170181440
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-29
[patent_title] => 'FUNGI ANTAGONISTIC TO XYLELLA FASTIDIOSA'
[patent_app_type] => utility
[patent_app_number] => 15/255827
[patent_app_country] => US
[patent_app_date] => 2016-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5825
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15255827
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/255827 | Fungi antagonistic to | Sep 1, 2016 | Issued |
Array
(
[id] => 16831000
[patent_doc_number] => 11007230
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2021-05-18
[patent_title] => Plasma derived from human umbilical cord blood for the treatment of neurodegenerative disorders
[patent_app_type] => utility
[patent_app_number] => 15/250239
[patent_app_country] => US
[patent_app_date] => 2016-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 29
[patent_no_of_words] => 9852
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 157
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15250239
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/250239 | Plasma derived from human umbilical cord blood for the treatment of neurodegenerative disorders | Aug 28, 2016 | Issued |